The board of directors of Huakang Biomedical Holdings Company Limited announced that, with effect from 31 January 2020: Dr. Tian Long is appointed as the medical advisor of the Group and will be primarily responsible for advisory service on research and development of male fertility in-vitro diagnostic reagents and auxiliary reproductive supplies, and business development of the Group in such industries. Dr. Tian has focused on andrology clinical and basic research for more than 18 years and has extensive working experience in the field of urology.